Exploring Connections Between Weight‐Loss Medications and Thyroid Cancer: A Look at the FDA Adverse Event Reporting System Database
ABSTRACT Aims GLP‐1 receptor agonists, such as semaglutide (Ozempic) and tirzepatide (Monjaro), have gained significant popularity for obesity management, but concerns have arisen about their potential link to thyroid cancer. This study investigates the association between thyroid cancer and weight‐...
| Published in: | Endocrinology, Diabetes & Metabolism |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/edm2.70038 |